Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Operating Expenses | 83,127 | 46,393 | 20,511 | 15,663 |
| Operating Income | -83,127 | -46,393 | -20,511 | -15,663 |
| Other Income | 659 | 33 | -296 | -2,453 |
| Pre-tax Income | -82,468 | -46,360 | -20,807 | -18,116 |
| Net Income Continuous | -82,468 | -46,360 | -20,807 | -18,116 |
| Net Income | $-82,468 | $-46,360 | $-20,807 | $-18,116 |
| EPS Basic Total Ops | -2.48 | -3.95 | -14.20 | -16.14 |
| EPS Basic Continuous Ops | -2.48 | -3.62 | -12.43 | -14.73 |
| EPS Diluted Total Ops | -2.48 | -3.95 | -14.20 | -16.14 |
| EPS Diluted Continuous Ops | -2.48 | -3.62 | -12.43 | -14.73 |
| EPS Diluted Before Non-Recurring Items | -2.48 | N/A | N/A | N/A |
| EBITDA(a) | $-81,892 | $-45,520 | $-19,845 | $-15,129 |